Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.32 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Anebulo Pharmaceuticals (ANEB) Share-based Compensation (2020 - 2025)

Updated

Anebulo Pharmaceuticals (ANEB) posted Share-based Compensation of $200,000 for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 66.7% from $600,000 a year earlier and down 15.8% from the prior quarter.

Analysis

Anebulo Pharmaceuticals (ANEB) Share-based Compensation (2020 - 2025) Analysis & Trends

For the trailing twelve months through Dec 31, 2025, Share-based Compensation at Anebulo Pharmaceuticals was $1.08 million, down 17.1% year-over-year; for FY2025 (ended Jun 30, 2025), it came in at $1.45 million, up 80.9% from FY2024.

  • Annual Share-based Compensation shows a four-year compound annual growth rate of 64.0% (FY2021 to FY2025).
  • In prior fiscal years, Anebulo Pharmaceuticals' Share-based Compensation was $800,000 in FY2024 (-9.6%), $884,723 in FY2023 (+84.1%), $480,661 in FY2022 (+140.4%) and $199,947 in FY2021.
  • Quarterly Share-based Compensation has run from a low of $34,173 in fiscal Q1 2022 to a high of $600,000 in fiscal Q2 2025 over five years.
  • On a year-over-year basis, Share-based Compensation increased in five of the last eight quarters, with growth averaging 35.4%.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was fiscal Q1 2023, with growth of 520.1%; the weakest was fiscal Q2 2026, with a decline of 66.7%.
  • According to Business Quant data, Share-based Compensation for the three prior fiscal quarters was $237,644 (Q1 2026), $340,304 (Q4 2025) and $300,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Anebulo Pharmaceuticals 13.15 Mn 13.15 Mn - 200,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 200,000.00
Sep 30, 2025 237,644.00
Jun 30, 2025 340,304.00
Mar 31, 2025 300,000.00
Dec 31, 2024 600,000.00
Sep 30, 2024 300,000.00
Jun 30, 2024 200,000.00
Mar 31, 2024 200,000.00
Dec 31, 2023 200,000.00
Sep 30, 2023 210,797.00
Jun 30, 2023 184,723.00
Mar 31, 2023 200,000.00
Dec 31, 2022 200,000.00
Sep 30, 2022 211,900.00
Jun 30, 2022 226,952.00
Mar 31, 2022 125,254.00
Dec 31, 2021 94,282.00
Sep 30, 2021 34,173.00
Jun 30, 2021 115,438.00
Mar 31, 2021 47,407.00
API Access

Anebulo Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ANEB&period=max&api_key=YOUR_API_KEY